08/25/2025
IVERMECTIN and FENBENDAZOLE TESTIMONIAL
23-Year-Old Edinburgh Woman with Stage 4 Lung Cancer and Thyroid Cancer Shows Astonishing Progress in Just 2 Months
It’s no exaggeration to say that we’re witnessing results that are rewriting what people thought was possible—especially for late-stage cancer. This story comes from Edinburgh, where a 23-year-old woman has seen dramatic improvement in her fight against advanced lung cancer using a protocol centered on Ivermectin and Fenbendazole.
Her Story:
At just 23 years old, this young woman from Edinburgh was given a devastating diagnosis: Stage 4 Non-Small Cell Lung Cancer (NSCLC). Already dealing with a medical history that included thyroid cancer, this second cancer came as a heavy blow to her and her family. Traditional options were offered—chemotherapy, radiation—but the prognosis was grim, and the side effects overwhelming.
That’s when her family began to research other options. They came across testimonies from others around the world who had used Ivermectin and Fenbendazole, two repurposed medications—originally used in veterinary and parasitic treatments—that were gaining attention in alternative cancer treatment circles.
The Treatment Plan:
On April 8, she began the following protocol under close supervision and support:
• Ive&$$$ctin: mg per kg of body weight per day
• Fenben@$zole: ***mg per day
• CBD Oil: 100 mg per day
• Chemotherapy was also started simultaneously by her oncologist, unaware of the complementary protocol.
The aim was to harness the synergistic effect of these compounds, which some early studies and anecdotal reports suggest may interfere with cancer cell metabolism, angiogenesis, and immune evasion.
The Results:
After just two months, the change was undeniable.
Her lingular mass, which had originally measured 5.3 x 5.6 cm, was now reduced to 2.5 x 4.0 cm. That’s an estimated 76% reduction in tumor volume, according to calculations run through Grok’s AI-assisted volumetrics.
This kind of tumor shrinkage is virtually unheard of in such a short time using chemotherapy alone. Even her oncologist, though cautious, reportedly admitted surprise at the rapid progress. But like many patients in similar situations, she hadn’t yet told her medical team about the additional protocol she was following.
A Bigger Picture:
This is not a one-off. Stories like hers are surfacing more frequently—especially among those combining traditional treatments with carefully chosen repurposed medications.
As the director of what has grown into the world’s largest Ivermectin telehealth Clinic, I’ve personally witnessed dozens of similar cases. Patients often come to us after being told there’s nothing more to be done. And time after time, we’re seeing hope where there was none.
And yet, it’s not all success and sunshine. You’d be shocked at the extent to which gatekeepers in the pharmaceutical and regulatory world go to—to suppress access to these treatments. It’s not a conspiracy theory. It’s a reality anyone on the front lines of alternative oncology is aware of.
Final Thoughts:
This 23-year-old woman’s journey is far from over. But in just 8 weeks, she’s seen a level of tumor shrinkage that has not only given her hope—it’s quite possibly extended her life. Her energy has returned, her appetite is back, and her scans are improving.
This testimonial is shared not as medical advice, but as inspiration. For patients, caregivers, and doctors willing to explore the frontiers of cancer therapy, stories like this represent a vital part of the conversation. **For educational purposes *Ivermectin *Fenbendazole *oncologist *Cancer Dr. Sarah D. Pace, MD,
